6 participants
Yttrium-90-labeled Daclizumab With Chemotherapy and Stem Cell Transplant for Hodgkin's Lymphoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-10-06
- Start Date:
- 2011-10-11
- Completion:
- 2014-11-16
Conditions
- Hodgkin Disease
- Hodgkin Lymphoma
Interventions
- PROCEDURE
- DRUG
- RADIATION